Sarcopenic Obesity - Eos SENOLYTIX

Sarcopenic Obesity

Greater lean-body-mass decline with tirzepatide than semaglutide in routine care revealed by body-composition digital phenotyping

April 13, 2026

Sustained visceral fat loss is associated with attenuated brain atrophy and improved cognitive function in late midlife

March 4, 2026

Unintended risks of sarcopenic obesity during weight-loss interventions in older people

February 5, 2026

Muscle-preserving therapies in the era of pharmacological weight loss

January 2, 2026

Prevalence of sarcopenic obesity in the older non-hospitalized population: a systematic review and meta-analysis

April 22, 2024

Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management

June 30, 2023

ECONOMIC IMPACT OF HOSPITALIZATIONS IN US ADULTS WITH SARCOPENIA

April 4, 2019

Skeletal Muscle Mass as a Mortality Predictor among Nonagenarians and Centenarians: A Prospective Cohort Study

February 20, 2019

Categories

Archives

© 2026 Eos SENOLYTIX.